Africa's health future hinges on its ability to finance and commercialize its own medical innovations, rather than rely on increasingly uncertain international funding, African science leaders have warned. In a commentary published in Nature Health, the inaugural cohort of the Calestous Juma Science Leadership Fellowship argue that decades of underinvestment have weakened Africa's ability to develop clinical solutions to the continent's huge disease burden.
African scientists push for homegrown pharma innovation
